Buparvaquone
Title: Buparvaquone
CAS Registry Number: 88426-33-9
CAS Name: 2-[[4-(1,1-Dimethylethyl)cyclohexyl]methyl]-3-hydroxy-1,4-naphthalenedione
Additional Names: 2-[(4-tert-butylcyclohexyl)methyl]-3-hydroxy-1,4-naphthoquinone; 3-(4-t-butylcyclohexyl)methyl-2-hydroxy-1,4-naphthoquinone
Manufacturers' Codes: BW-720C
Trademarks: Butalex (Coopers)
Molecular Formula: C21H26O3
Molecular Weight: 326.43
Percent Composition: C 77.27%, H 8.03%, O 14.70%
Literature References: Analog of antimalarial hydroxynaphthoquinones; t-butyl deriv of parvaquone, q.v. Prepn: A. T. Hudson, A. W. Randall, EP 77550; eidem, US 4485117 (1983, 1984 both to Wellcome). In vivo and in vitro antiprotozoal activity: A. T. Hudson et al., Parasitology 90, 45 (1985); N. McHardy et al., Res. Vet. Sci. 39, 29 (1985). Treatment of bovine theileriosis: S. Dhar et al., Vet. Rec. 119, 635 (1986). Efficacy as a chemoimmunoprophylactic of theileriosis: eidem, ibid. 120, 375 (1987).
Properties: Crystals, mp 124-125°. LD50 orally in rats: >2 g/kg (Hudson).
Melting point: mp 124-125°
Toxicity data: LD50 orally in rats: >2 g/kg (Hudson)
Therap-Cat-Vet: Antiprotozoal (Theileria).

Others monographs:
RisperidoneTinoridineAluminum BoroformateProcymate
DoxycyclineDemetonDigitalinMagnesium Fluoride
BasiliximabCaro's AcidSamarium CobaltPhenprobamate
CloprednolDehydroascorbic Acid9-AminocamptothecinCalcium Permanganate
©2016 DrugLead US FDA&EMEA